Ye J - Search Results

1

Crizotinib-resistant MET mutations in gastric cancer patients are sensitive to type II tyrosine kinase inhibitors.

Shen B, Wu F, Ye J, Liang R, Wang R, Yu R, Wu X, Shao YW, Feng J. Shen B, et al. Among authors: ye j. Future Oncol. 2019 Aug;15(22):2585-2593. doi: 10.2217/fon-2019-0140. Epub 2019 Jul 24. Future Oncol. 2019. PMID: 31339066

2

Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma.

Zhao YN, Zhang YQ, Ye JZ, Liu X, Yang HZ, Cong FY, Xiang BD, Wu FX, Ma L, Li LQ, Ye HH. Zhao YN, et al. Exp Ther Med. 2016 Dec;12(6):3813-3819. doi: 10.3892/etm.2016.3810. Epub 2016 Oct 17. Exp Ther Med. 2016. PMID: 28105115 Free PMC article.

3

The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma.

Liang R, Lin Y, Yuan CL, Liu ZH, Li YQ, Luo XL, Ye JZ, Ye HH. Liang R, et al. Cell Prolif. 2017 Jun;50(3):e12340. doi: 10.1111/cpr.12340. Epub 2017 Mar 1. Cell Prolif. 2017. PMID: 28247446 Free PMC article.

4

High expression of RBM8A predicts poor patient prognosis and promotes tumor progression in hepatocellular carcinoma.

Liang R, Lin Y, Ye JZ, Yan XX, Liu ZH, Li YQ, Luo XL, Ye HH. Liang R, et al. Oncol Rep. 2017 Apr;37(4):2167-2176. doi: 10.3892/or.2017.5457. Epub 2017 Feb 15. Oncol Rep. 2017. PMID: 28259942

5

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.

Wu FX, Chen J, Bai T, Zhu SL, Yang TB, Qi LN, Zou L, Li ZH, Ye JZ, Li LQ. Wu FX, et al. Among authors: ye jz. BMC Cancer. 2017 Sep 12;17(1):645. doi: 10.1186/s12885-017-3545-5. BMC Cancer. 2017. PMID: 28899349 Free PMC article.

6

APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.

Yuan CL, He F, Ye JZ, Wu HN, Zhang JY, Liu ZH, Li YQ, Luo XL, Lin Y, Liang R. Yuan CL, et al. Oncotarget. 2017 Aug 2;8(35):59720-59728. doi: 10.18632/oncotarget.19814. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938675 Free PMC article.

7

Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.

Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX. Ye JZ, et al. World J Gastroenterol. 2017 Nov 7;23(41):7415-7424. doi: 10.3748/wjg.v23.i41.7415. World J Gastroenterol. 2017. PMID: 29151695 Free PMC article.

8

Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update.

Ye JZ, Wang YY, Bai T, Chen J, Xiang BD, Wu FX, Li LQ. Ye JZ, et al. Oncotarget. 2017 Jun 27;8(54):93258-93278. doi: 10.18632/oncotarget.18735. eCollection 2017 Nov 3. Oncotarget. 2017. PMID: 29190996 Free PMC article. Review.

9

Negative regulation of MAVS-mediated innate immune response by ASC.

Han Y, He X, Wei C, Song T, Zou L, Li Z, Ye J, Qi L, Li L, Zhong H, Wu F. Han Y, et al. Among authors: ye j. Mol Cell Biochem. 2018 Aug;445(1-2):35-43. doi: 10.1007/s11010-017-3249-9. Epub 2017 Dec 26. Mol Cell Biochem. 2018. PMID: 29280086

10

GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells.

Ye JZ, Yan SM, Yuan CL, Wu HN, Zhang JY, Liu ZH, Li YQ, Luo XL, Lin Y, Liang R. Ye JZ, et al. J Cancer. 2018 Jan 1;9(2):415-423. doi: 10.7150/jca.19185. eCollection 2018. J Cancer. 2018. PMID: 29344288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,064 results

Search Page

Filters